XML 69 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2024
INCOME TAXES  
Income before income taxes

(millions)

    

2024

    

2023

    

2022

United States (U.S.)

    

$1,035.3

    

    

$408.9

    

    

$295.6

    

International

 

1,535.9

1,346.6

1,047.8

Total

$2,571.2

$1,755.5

$1,343.4

Provision (benefit) for income taxes

(millions)

    

2024

    

2023

    

2022

U.S. federal and state

    

$301.3

$137.6

$145.7

    

International

 

322.6

280.0

231.4

Total current

 

623.9

417.6

377.1

U.S. federal and state

 

(143.1)

(40.1)

(78.9)

International

 

(41.5)

(15.0)

(63.7)

Total deferred

 

(184.6)

(55.1)

(142.6)

Provision for income taxes

$439.3

$362.5

$234.5

Net deferred tax assets and deferred tax liabilities

December 31 (millions)

    

2024

    

2023

Deferred tax assets

    

    

    

    

Pension and post-retirement benefits

$68.2

$82.1

Other accrued liabilities

152.5

162.0

Lease liability

 

 

176.7

 

135.9

Credit carryforwards

105.1

83.7

Capitalization of R&D costs

246.5

180.9

Loss carryforwards

 

 

92.9

 

57.3

Share-based compensation

 

 

54.2

 

54.5

Deferred income

72.4

27.9

Deferred interest

85.2

64.3

Other, net

 

 

32.8

 

49.0

Valuation allowance

 

 

(77.8)

 

(65.7)

Total deferred tax assets

 

 

1,008.7

 

831.9

Deferred tax liabilities

Goodwill

(133.9)

(160.1)

Intangible assets

 

 

(410.4)

 

(451.3)

Property, plant and equipment

 

 

(310.7)

 

(332.3)

Lease asset

(177.8)

(136.1)

Financing

(43.3)

(32.1)

Other, net

 

 

(57.1)

 

(18.9)

Total deferred tax liabilities

 

 

(1,133.2)

(1,130.8)

Net deferred tax liabilities balance

($124.5)

($298.9)

Reconciliation of the statutory U.S. federal income tax rate to the company's effective income tax rate

    

2024

2023

2022

Statutory U.S. rate

21.0

%  

21.0

%

21.0

%

State income taxes, net of federal benefit

1.5

 

1.4

 

1.3

Foreign operations

(1.2)

 

(0.5)

 

(0.8)

Excess stock benefits

(0.7)

(0.3)

(0.4)

R&D credit

(0.9)

 

(1.3)

 

(1.4)

Foreign derived intangible income

(1.9)

(1.2)

(1.8)

Change in valuation allowance

0.6

 

0.5

 

0.7

Legal entity rationalization

-

0.1

(1.5)

Sale of global surgical solutions business

1.1

-

-

Capital losses

(3.4)

-

-

Other, net

1.0

 

0.9

 

0.4

Effective income tax rate

17.1

%

20.6

%

17.5

%

Reconciliation of the beginning and ending amount of gross liability for unrecognized tax benefits

(millions)

    

2024

    

2023

2022

Balance at beginning of year

$24.2

$24.9

$25.1

Additions based on tax positions related to the current year

    

4.6

 

5.8

 

2.7

Additions for tax positions of prior years

 

 

11.6

 

1.7

 

3.6

Reductions for tax positions of prior years

 

 

-

 

-

 

(1.5)

Reductions for tax positions due to statute of limitations

 

 

(0.7)

 

(2.7)

 

(0.7)

Settlements

 

 

(5.3)

 

(5.5)

 

(3.4)

Foreign currency translation

 

 

(0.3)

 

-

 

(0.9)

Balance at end of year

$34.1

$24.2

$24.9